Potential Cost of Multi-Cancer Detection Tests to Medicare
Discuss this preprint
Start a discussion What are Sciety discussions?Listed in
This article is not in any list yet, why not save it to one of your lists.Abstract
Multi-Cancer Detection (MCD) tests can detect more than 50 different types of cancer using a blood test. Recently passed law in the U.S. guarantees that Medicare will pay for these tests when they are FDA approved and show evidence for clinical benefit. This manuscript provides estimates of the cost of MCD tests to Medicare under different assumptions of cost per test, eligibility, and screening uptake in the eligible population. This manuscript additionally estimates the cost of follow-up testing resulting from false positive results, which are considered avoidable costs caused by the screening test.
